Old Web
English
Sign In
Acemap
>
authorDetail
>
Lorenzo Guizzaro
Lorenzo Guizzaro
European Medicines Agency
Clinical trial
Medicine
Intensive care medicine
potential impact
optimal treatment
5
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The opportunity of patient-journey studies for academic clinical research in oncology.
2021
BMJ Open
Francesco Perrone
Raimondo Di Liello
Piera Gargiulo
Laura Arenare
Lorenzo Guizzaro
Paolo Chiodini
Ciro Gallo
Maria Carmela Piccirillo
Show All
Source
Cite
Save
Citations (0)
Ethical Aspects of Regulating Oncology Products.
2021
Recent results in cancer research
Lorenzo Guizzaro
Spyridon Drosos
Ulrik Kihlbom
Francesco Pignatti
Show All
Source
Cite
Save
Citations (0)
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study.
2021
Pharmaceutical Statistics
Florian Lasch
Lorenzo Guizzaro
Lukas Aguirre Dávila
Kirsten Müller-Vahl
Armin Koch
Show All
Source
Cite
Save
Citations (0)
The use of a variable representing compliance improves accuracy of estimation of the effect of treatment allocation regardless of discontinuation in trials with incomplete follow-up
2020
Statistics in Biopharmaceutical Research
Lorenzo Guizzaro
Frank Pétavy
Robin Ristl
Ciro Gallo
Show All
Source
Cite
Save
Citations (2)
Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
2019
British Journal of Clinical Pharmacology
Frank Pétavy
Lorenzo Guizzaro
Inês Antunes dos Reis
Steven Teerenstra
Kit C.B. Roes
Show All
Source
Cite
Save
Citations (4)
1
map